v-A retrospective autopsy study of 627 patients with systemic cancer disclosed 153 patients with metastasis to the central nervous system (CNS) and 13 patients with intramedullary spinal cord metastasis (ISM). Thus, the frequency of ISM was 8.5% of cases of metastasis to the CNS and 2.1% of all cases of cancer. Bronchogenic carcinoma accounted for 11 cases of ISM, and breast carcinoma and melanoma for the other two. There were two distinct patterns of spinal cord involvement, indicating spread of tumor to the cord by two different routes. In nine of the 13 ISM patients a metastasis was found deep within the spinal cord, unassociated with leptomeningeal carcinomatosis; this most likely resulted from hematogenous spread of tumor from a pulmonary source. In the other four patients there was focal or multifocal direct extension of leptomeningeal metastatic tumor across the pia into the parenchyma of the cord. Only four of the 13 patients had a clinical myelopathy; in three of these four this was the presenting feature of an occult lung cancer.
of patients with certain cancers, as a result of improved treatment, has been accompanied by a greater frequency of cerebral metastases. 7'13 Although most authorities are in agreement on the frequency of cerebral metastases ~4 and on the routes of spread by which they reach the brain, 23 these aspects of intramedullary spinal cord metastasis (ISM) remain a matter of controversy.5'~~ Most of the over 100 cases of ISM in the literature are single case reports. 51~ Among the series supplying the pathological features of autopsy-proven cases of ISM, only three 5'8'~~ include more than four cases, and none reports more than nine cases, j~ At the Cleveland Metropolitan General Hospital, the same neuropathologist (Dr. Betty Q. Banker) has examined all autopsied cases for 22 years; this has provided an unusually consistent approach to the autopsy material of a large general hospital. A retrospective autopsy study of the 13 cases of ISM examined during this period was therefore undertaken.
Clinical Material and Methods
The reports of the 7 330 autopsies performed between 1962 and early 1984 were reviewed. All cases of invasive carcinoma and sarcoma were included in the study (Table 1) . Cases of leukemia, lymphoma, multiple myeloma, adenocarcinoma confined within the capsule of the prostate, cervical carcinoma in situ, non-melanoma skin cancer, and primary CNS cancer were excluded (see Discussion). Brains were removed at autopsy unless permission to do so was denied by the patient's family; spinal cords were less consistently removed (Table 1) . The following six tumor types were associated with one case of central nervous system (CNS) metastasis: liver 25 (2.2%), ovary 15 (1.3%), corpus uteri 15 (1.3%), sarcoma 12 (1.0%), paranasal sinus 4 (0.3%), and parotid 1 (0.1%). The remaining tumor types were not associated with CNS metastasis: buccal cavity and tongue 15 (1.3%), non-melanoma skin, deeply invasive 2 (0.2%), and vagina 1 (0.1%).
FIG. 1. Case 3.
Spinal cord in transverse section with enlar.gement due to tumor at T-8 and T-9 and normal configuration below the tumor, at T-12.
In the classification of the material, metastasis to the CNS was defined as invasion of the parenchyma or leptomeninges of the brain a n d / o r spinal cord. Metastasis to the spinal cord was defined as parenchymal invasion, with or without leptomeningeal involvement.
At autopsy, the thoracic and lumbosacral spinal cord was removed by the anterior route. W h e n removed, the cervical portion was taken posteriorly. After fixation, the cord was cut at 5-to 10-mm intervals, and blocks were processed for light microscopy. W h e n the cord appeared grossly normal, blocks from one cervical, two thoracic, and one lumbosacral level were studied. When a gross abnormality was present, multiple blocks were made at the level of the lesion, as well as one or two blocks from each segment above and below the lesion.
Results
Thirteen patients with ISM were studied. W h e n expressed as a percentage of patients undergoing cord necropsy, the frequency of ISM was 2.1% of all patients with carcinoma and sarcoma and 8.5% of all patients with metastasis to the CNS. The primary t u m o r types encountered are shown in Table 2 .
The findings at general autopsy in the 13 patients with ISM included widespread visceral metastases. There was primary or secondary involvement of the lung in all cases. No metastases were found in the spinal epidural space, although osseous vertebral metastases were c o m m o n . In 11 patients there were multiple cerebral metastases; in two patients the spinal metastasis was solitary, that is, u n a c c o m p a n i e d by metastases elsewhere in the CNS.
Two distinct patterns of metastatic involvement of the spinal cord were discerned. In nine patients, there was primary involvement of the spinal parenchyma by tumor. In the remaining four patients, parenchymal invasion was secondary to involvement of the spinal leptomeninges.
Primary Parenchymal Involvement
Five of the nine metastases of this type were large enough to be detected grossly (Table 3 , Group IA). The configuration of the cord was distorted and enlarged at the level of the tumor (Fig. 1 ) . The metastases occupied one to four adjacent segments of the cord (Table 3) . In Case 3, the spinal parenchyma was completely replaced by tumor ( Fig. 1 ), but in the other four patients a roughly spherical mass was situated deep in the posterior horn and the adjacent white matter (Fig. 2) . In Case 2 there were two separate metastases, at the cervical and lumbar levels; of the remaining four cases of ISM, two were located in the lumbosacral cord, one in the mid-thoracic cord, and one in the high cervical cord (Table 3) . Where the spinal parenchyma was completely replaced, there was focal direct extension of tumor into the subarachnoid space (Case 3); otherwise the leptomeninges were devoid of tumor. In one patient, centrifugal spread of tumor from the posterior horn into the dorsal root was evident (Fig. 2 lower) . Each metastasis showed central or patchy areas of necrosis (Fig. 2) .
In four of the five Group IA patients with large metastases there was clinical evidence of myelopathy (Table 3 ). The deficit evolved rapidly and reached its peak in 10 to 21 days in every case, and consisted of an approximately symmetrical paraparesis or tetraparesis. Pain, paresthesias or dysesthesias (in a radicular or less well defined localization), a sensory level, and urinary sphincter symptoms were present in all patients. There were no clinical features by which ISM could be distinguished from an extradural compressive lesion. These four patients survived 10 days to 7 months (10 days, 2 89 months, 3 months, and 7 months) after the onset of cord symptoms. All died as a result of widespread metastatic disease. Case 4, the only patient in whom the diagnosis of ISM was made in life, was treated with irradiation, but no improvement occurred.
Lumbar puncture on admission in the four symptomatic Group IA patients revealed normal cerebrospinal fluid (CSF) pressure. On analysis, the CSF contained a mildly elevated protein concentration (mean 76 mg%, range 66 to 82 mg%), and normal cell counts. Cytological evaluation of the CSF disclosed no tumor cells. Myelography at admission was normal in Cases 1, 2, and 3, but in Case 4 revealed widening of the lumbosacral cord. In Case 2 repeat myelography 11 days later showed enlargement of the cord at the cervical and lumbar levels.
The clinical presentation of Case 4 was that of myelopathy complicating a known case of lung cancer. The myelographic picture of an enlarged spinal cord led to the diagnosis of ISM in life. However, in Cases 1, 2, and 3, myelopathy was the presenting feature of an occult carcinoma. The diagnosis of lung cancer was established on transbronchial biopsy of a coin lesion in Case 2, but awaited autopsy in Cases 1 and 3. In attempting to account for the spinal cord disease, diagnostic considerations included paraneoplastic necrotizing myelopathy (Case 2), multiple sclerosis (Case 3), and idiopathic acute necrotizing myelopathy (Case 1).
In the other four cases of primary parenchymal metastasis (Table 3 , Group IB), the tumor was too small to be detected grossly but was found fortuitously on microscopic examination of routine spinal cord blocks. Three of these metastases (Cases 6, 7, and 8) were located in the gray matter of the posterior horn ( described a prospective study.
-? "Cancer" includes sarcoma but excludes lymphoma and leukemia, except in the study by Hashizume and Hirano. 8 which includes ~'malignancies" without further definition.
The proportion of patients with central nervous system (CNS) metastasis to patients with cancer undergoing postmortem examination of brain and spinal cord appears in parentheses.
Parenchymal Invasion Secondary to Leptomeningeal Involvement
Four of the 40 cases of leptomeningeal carcinomatosis in our series were associated with invasion of the parenchyma of the cord (Table 3 , Group II). The avenue of entry varied with the severity of the leptomeningeal tumor infiltration. In Cases 10 and 11, there was heavy infiltration throughout the craniospinal leptomeninges. Invading tumor cells entered the spinal cord by directly traversing the pia surrounding the cord (Fig. 4) . In Cases 12 and 13, there was light patchy infiltration of the spinal leptomeninges. Parenchymal invasion occurred from (perivascular) Virchow-Robin spaces (Fig. 5 left) . These conveyed tumor cells from the subarachnoid space surrounding the cord into the depth of the cord. The pia mater membrane, which partitions the CNS from the perivascular space, was then breached by tumor cells, which proliferated and expanded as a parenchymal growth (Fig. 5 right) .
No myelopathic features were recognized in life in these four patients. In the two cases with heavy tumor infiltration, the diagnosis of meningeal carcinomatosis was made on the basis of typical clinical and CSF finding. 2~
Discussion
The characteristics of the population studied indicate that it was not specially selected. It was drawn from a general community hospital, not a specialty referral center. After allowance is made for the exclusion of lymphoma and leukemia, the frequency distribution of the primary tumors in our autopsy population (Table  2 ) is similar to that of the cancer mortality statistics in the United States as a wholeJ 8 The overall frequency of CNS metastases in our study (approximately 22%, see Table 1 ) agrees with those observed by others in similar populations. ~4 Finally, lymphoma and leukemia having been excluded, the distribution of CNS metastases by primary tumor type (Table 2) is roughly comparable to those of other autopsy series, reviewed by Posner and Chernik, ~4 although there is a wide range of variation amongst these series. For example, the frequency of CNS metastases among cases of melanoma ranges from 27% to 92%; ~4 in our series it was 44%, which nevertheless is lower than most estimates. ~4 This explains the unusual occurrence in our series of more metastases from colonic and rectal carcinoma than from melanoma.
In the selection of cases of invasive cancer (irrespective of metastasis to the CNS), leukemia, lymphoma, and myeloma were excluded in the present study. Two of the three previous autopsy studies of CNS metastasis from which a frequency of ISM can be calculated also excluded these types of cancer, 4'j~ and the third 8 included cases of "malignancy" without further qualification. A cogent reason for excluding these tumors is that their biological behavior in relation to the CNS has already been well described 9'~2'~5 and differs markedly from that of the carcinomas, Estimates of the frequency of ISM vary widely (Table  4 ). In the present study the frequency is 70% to 130% higher than previously reported. There are two major reasons for the discrepancies. Common to all the retrospective series is the problem of selective bias, chiefly with reference to the decision as to whether to remove the spinal cord at autopsy. In our laboratory there is a strong interest in clinicopathological correlation, and this undoubtedly influenced the extent of autopsy study. In our material, the frequency of cerebral metastases was higher in those patients from whom the cord was taken at autopsy (24%) than in those from whom it was not taken (18%, Table 1 ). Although this difference does not attain statistical significance (chi square = 2.9, p > 0.05), it does suggest that the presence of clinical neurological abnormalities influenced the prosector's decision to remove the cord at autopsy. In contrast, in the prospective study of Chason, et al., 4 the brain and spinal cord were removed in every case of invasive carcinoma, perhaps contributing to the lower frequency of ISM observed by these authors. An even greater problem common to all autopsy studies is the sampling procedure. An indeterminate number of microscopic metastases must be overlooked when only a few routine blocks of cord are examined microscopically. Lesions detected solely by microscopy were not encountered by Hashizume and Hirano, 8 and are not mentioned in the two other studies. 4' 1~ Eight of our 13 cases (Table 3 , Groups IB and II) were discovered in this way, and this probably accounts for the higher frequency of ISM in our study. Edelson, et al., 5 have suggested that the frequency of ISM is higher than might be expected? They compared the ratio of spinal cord weight to brain weight (2%) with the ratio of the number of patients with ISM to the number of patients with metastases to brain and cord combined (5%), using data from the autopsy series of Chason, et al., 4 and concluded that the spinal cord was more susceptible to invasion than the CNS as a whole. However, by neglecting to take into consideration multiple, uncounted intracerebral metastases, these authors reached their conclusion on fallacious grounds. In making such a comparison of the vulnerability of different regions of the CNS to metastatic invasion, it is essential to compare the total number of individual metastases in those regions, not merely numbers of patients with metastases. Since these data are not usually available in autopsy protocols, other authors making similar analyses ~'22 have confined themselves to cases of solitary metastasis. In our material, there were 39 cases of solitary CNS metastasis, of which two (5.1%) were in the cord. These numbers are too small for statistically valid conclusions.
Bronchogenic carcinoma accounted for 41% of 100 cases of ISM collected from the literature, ~~ or 45% if lymphoma is excluded. In the present series, 11 of the 13 cases (85%) were due to bronchogenic carcinoma (Table 3 ). This frequency may represent a more realistic estimate, as the other figure is derived in large part from isolated case reports. Undoubtedly, many of the latter cases excited interest because they described unusual tumors metastatic to the cord. This discrepancy is not, however, due to over-representation of lung cancer in our series; the frequency of bronchogenic carcinoma as a source of metastasis to the CNS in our series (60.9%, Table 2 ), is comparable to that in other autopsy series. 14 Two different types of metastatic involvement of spinal parenchyma were found in this study. These seem to correspond to two different routes of spread of tumor to the spinal cord. The metastases of Group I (Table 3) probably originated in primary or secondary deposits in the lung, reached the heart by invasion of the pulmonary vein, and spread from the heart as systemic arterial emboli to the cord. Several points favor this scheme, in spite of our finding no arterial tumor emboli in the spinal cords. In all Group I patients there were: pulmonary deposits,of tumor; widespread metastases in other organs supplied only by the systemic circulation (such as the adrenal gland, kidney, brain, and bone); and no other source, such as the subarachnoid space, from which a metastatic focus might have extended into cord parenchyma. The scheme of hematogenous spread of tumor through systemic arteries can also explain why eight of the nine Group I tumors were situated deep in the posterior horn or adjacent white matter. Arterial perfusion of the spinal gray matter is five times greater than that of white matter; ~6 the density of capillary networks increases with neuronal packing density, 2~ which is greatest in the posterior horn; 6 and the ventral posterior horn is within the terminal field of supply of the central artery. ~~ Involvement of the parenchyma of the cord in our Group II patients was a complication of leptomeningeal carcinomatosis, the result of direct extension of tumor from the subarachnoid space (that surrounding the cord and the Virchow-Robin space) into the cord. Case 13 illustrates the need for a careful microscopic search of the subarachnoid space, in which a tiny infiltrate may account for what appears to be a primary parenchymal metastasis (Fig. 5) . None of our cases of this type showed clinical signs of cord involvement, but it is likely that this phenomenon accounts for the occasional patient with meningeal carcinomatosis who later develops signs of a myelopathy.
Several other routes by which metastases might reach the spinal cord have been suggested. The role of Batson's venous plexus 2 need not be considered in our patients, because in each, as noted above, a pulmonary source was present, and the distribution of visceral metastases indicated dissemination through systemic arteries. A metastasis in the spinal subdural space was thought to have extended centripetally via nerve roots into the parenchyma of the cord; 5 however, our finding of clear-cut centrifugal extension of tumor from parenchyma into dorsal roots (Fig. 2 lower) argues for caution in interpreting this report. Direct extension of metastatic tumor from the spinal extradural space, through the dura and into the cord, as well as spread along perineural lymphatic ducts to subarachnoid space and thence to cord parenchyma have been suggested, but no pathological confirmation of these hypothetical routes has been adduced. 3 In our four symptomatic patients, the clinical features of the myelopathy, including neurological symptoms and signs, course, and length of survival, were similar to those recently reviewed by others. 5'~~ Most notable is the rapid course of this disease. In an analysis of 47 patients (40 from the literature, and seven of their own) Jellinger, et al., ~o found that the full neurological deficit developed in less than 1 week in nine patients, in less than 1 month in 20 patients, and in less than 6 months in 18 patients. ~~ In our patients the period was 10 days to 3 weeks. This rapid clinical progression correlates with the observed tumor necrosis (Fig. 2) , which is a pathological sign of rapid growth in a neoplasm. Alterations of the CSF chemistry, other than a nonspecific elevation in protein, did not occur in our patients or in most of those previously reported; 5'~~ in particular, tumor cells were not present in the CSF. Myelography failed to disclose enlargement of the spinal cord in two of our four symptomatic patients, and this is in accord with the experience of others, s~~ Our patients with symptomatic myelopathy presented two different clinical problems. Case 4, like most reported patients with ISM, ~~~ presented as a case of "malignant paraplegia," that is, myelopathy developing during the course of a known systemic malignancy. The differential diagnosis of acute or subacute malignant paraplegia includes ISM, extradural spinal metastasis, paraneoplastic necrotizing myelopathy, and the dose-related delayed myelopathy of irradiation. Extradural compression is evident at myelography. The swelling of the spinal cord seen at myelography in some patients with radiation myelopathy can be confused with the enlargement caused by ISM. However, the segments of the cord liable to the development of radiation damage can usually be determined from radiotherapy records; this information and dosimetric analysis of the therapy may help to rule out this complication of treatment. For example, if radiation therapy was delivered to the chest or in a small dose, then it cannot account for a lumbosacral myelopathy. This differential diagnosis is important, because radiation therapy is the only treatment available for ISM. The myelogram may be normal or show cord enlargement in necrotizing myelopathy, as in radiation myelopathy and ISM. However, in necrotizing and radiation myelopathy the enlargement is due to edema accompanying acute tissue destruction, whereas in ISM it is due to the presence of a growing tumor. Therefore, it is reasonable to expect that serial myelography (or computerized tomography (CT) scans) might show the cord enlarging with time in ISM (as in our Case 2) but shrinking in the other two diseases. Thus, repeated myelography or spinal CT may be of value in this differential diagnosis.
Cases 1, 2, and 3 were not known to have systemic cancer, and so the diagnostic problem presented by them was simply that of an acute or subacute myelopathy. Heretofore, it has been thought rare that the symptoms of ISM should present before those of the primary tumor. ~7 However, since the majority of our symptomatic patients presented in this way, we suggest that ISM as the presenting feature of an occult carcinoma be considered in the differential diagnosis of any acute or subacute myelopathy, especially in middleaged and elderly patients. At autopsy, primary or metastatic carcinoma was found in the lungs of all 13 of our patients and in the brains of 11; in view of this, a search for underlying malignancy should include a chest x-ray film and a CT scan of the head. In an undiagnosed case, repetition of the myelogram may be of value, for the reason given in the preceding paragraph.
